Correlation Between Tandem Diabetes and CureVac NV
Can any of the company-specific risk be diversified away by investing in both Tandem Diabetes and CureVac NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tandem Diabetes and CureVac NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tandem Diabetes Care and CureVac NV, you can compare the effects of market volatilities on Tandem Diabetes and CureVac NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tandem Diabetes with a short position of CureVac NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tandem Diabetes and CureVac NV.
Diversification Opportunities for Tandem Diabetes and CureVac NV
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Tandem and CureVac is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Tandem Diabetes Care and CureVac NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CureVac NV and Tandem Diabetes is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tandem Diabetes Care are associated (or correlated) with CureVac NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CureVac NV has no effect on the direction of Tandem Diabetes i.e., Tandem Diabetes and CureVac NV go up and down completely randomly.
Pair Corralation between Tandem Diabetes and CureVac NV
Given the investment horizon of 90 days Tandem Diabetes Care is expected to under-perform the CureVac NV. In addition to that, Tandem Diabetes is 1.1 times more volatile than CureVac NV. It trades about -0.16 of its total potential returns per unit of risk. CureVac NV is currently generating about 0.01 per unit of volatility. If you would invest 305.00 in CureVac NV on December 26, 2024 and sell it today you would lose (14.00) from holding CureVac NV or give up 4.59% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Tandem Diabetes Care vs. CureVac NV
Performance |
Timeline |
Tandem Diabetes Care |
CureVac NV |
Tandem Diabetes and CureVac NV Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tandem Diabetes and CureVac NV
The main advantage of trading using opposite Tandem Diabetes and CureVac NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tandem Diabetes position performs unexpectedly, CureVac NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CureVac NV will offset losses from the drop in CureVac NV's long position.Tandem Diabetes vs. DexCom Inc | Tandem Diabetes vs. Inspire Medical Systems | Tandem Diabetes vs. Penumbra | Tandem Diabetes vs. Insulet |
CureVac NV vs. Joby Aviation | CureVac NV vs. Siriuspoint | CureVac NV vs. Kinsale Capital Group | CureVac NV vs. Cebu Air ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |